Clinical trial
MulticEnter Trial of Rivaroxaban for Early disCharge of pUlmonaRY Embolism From the Emergency Department
NCT02584660 is registered in ClinicalTrials.gov with Janssen Scientific Affairs, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MulticEnter Trial of Rivaroxaban for Early disCharge of pUlmonaRY Embolism From the Emergency Department
- Lead sponsor
- Janssen Scientific Affairs, LLC
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 15, 2015
- Completion date
- March 22, 2017
- Enrollment
- 114 (actual)
- Sites
- 50
Conditions
As the registry lists them; a condition with its own page is linked.